Skip to main content

Table 6 Different HPV subtype infection rates among NILM, ASC, LSIL, and HSIL, respectively

From: Characteristics of women infected with human papillomavirus in a tertiary hospital in Beijing China, 2014–2018

HPV subtype

NILM (%)

N = 19,493

ASC (%)

N = 858

LSIL (%)

N = 561

HSIL (%)

N = 327

HPV16

591 (3.03)

130 (15.15)

73 (13.01)

148 (45.26)

HPV18

234 (1.20)

46 (5.36)

16 (2.85)

16 (4.89)

HPV31

196 (1.01)

33 (3.85)

19 (3.39)

16 (4.89)

HPV33

103 (0.53)

26 (3.03)

14 (2.50)

12 (3.67)

HPV35

151 (0.77)

26 (3.03)

17 (3.03)

11 (3.36)

HPV39

368 (1.89)

68 (7.93)

41 (7.31)

13 (3.98)

HPV45

62 (0.32)

16 (1.86)

5 (0.89)

3 (0.92)

HPV51

296 (1.52)

79 (9.21)

76 (13.54)

14 (4.28)

HPV52

764 (3.92)

131 (15.27)

59 (10.52)

32 (9.79)

HPV56

272 (1.40)

57 (6.64)

98 (17.47)

8 (2.45)

HPV58

662 (3.40)

132 (15.38)

58 (10.34)

57 (17.43)

HPV59

253 (1.30)

39 (4.55)

18 (3.21)

6 (1.83)

HPV68

180 (0.92)

46 (5.36)

27 (4.81)

5 (1.53)

  1. HPV human papillomavirus, NILM negative for intraepithelial lesions or malignancy, ASC atypical squamous cells, LSIL low grade squamous intraepithelial lesion, HSIL high grade squamous intraepithelial lesion